Sources & References
Peer-reviewed research
GLP-1 receptor agonists in the treatment of type 2 diabetes - state-of-the-art
Research FAQ
Compound and research-use information
What is GLP-1 S?
GLP-1 S is a synthetic peptide research compound belonging to the glucagon-like peptide-1 (GLP-1) receptor agonist class. It is supplied strictly for laboratory research use.
What is GLP-1 S studied for in the research setting?
GLP-1 S is used in vitro and in preclinical research as a reference GLP-1 receptor agonist to study GLP-1 receptor binding and downstream signaling in cell and animal metabolic-pathway models. It is a mechanistic research tool only and is not evaluated here for any clinical use.
What form is Aurevena's GLP-1 S supplied in?
GLP-1 S is supplied as a lyophilized (freeze-dried) powder. Every batch is tested by independent, accredited U.S. laboratories for purity and identity, with the Certificate of Analysis published on this product page. Store lyophilized peptide cold and protected from light, and avoid repeated freeze-thaw cycles.
Is GLP-1 S intended for human use?
No. GLP-1 S is sold by Aurevena strictly for laboratory and research use only. It is not a drug, dietary supplement, cosmetic, or medical device, and is not intended for human or veterinary use, consumption, or for the diagnosis, treatment, cure, or prevention of any disease.





